Evento

Antiproliferative effect of Coleus Neochilus extract on human breast cancer cell lines

Mayora Justel, Carla Luciana ; Esandi, María del Carmen ; Villamil, Carlos Baldomero ; Gomila, Carla ; Salvador, Gabriela Alejandra Icon; Bouzat, Cecilia Beatriz Icon; Luthy, Isabel Alicia Icon; Alza, Natalia Paola Icon; Bruzzone, Ariana Icon

Otros responsables

Fecha

2022

Editorial

Fundación Revista Medicina

Revista

Título del libro

Nombre del evento

XVII Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXX Reunión Anual de La Sociedad Argentina de Inmunología; 3er Congreso Franco-Argentino De Inmunología y Reunión Anual 2022 de La Sociedad Argentina De Fisiología

Fecha del evento

2022-11-16

Institución organizadora

Sociedad Argentina de Investigación Clinica
Sociedad Argentina de Inmunología
Sociedad Argentina de Fisiología

ISSN

0025-7680

eISSN

1669-9106

ISBN

Idioma

Inglés

Tipo del evento

Reunión

Clasificación temática

Resumen

The Plectranthus species have a rich diversity of ethnobotanical uses. Nevertheless, the most frequently use of these species is for their medicinal properties. This work focuses on Coleus neochilus (Schltr.) Codd, also known as “boldo rastrero” (BR), a specie closely akin to the genus Plectranthus, and its effect on human breast can- cer cell lines. A crude ethanolic extract of leaves of BR was prepared. BR incubation decreased cell viability in MCF-7, MDA-MB-231 and T47D cancer cell lines. The extract concentration that caused a 50% inhibition in cell viability (IC50) was lower for tumor cells than for non- tumor cells (about 45, 19, 26 vs 50 for MCF-7, MDA-MB-231, T47D and MCF-10A respectively). At 10 μg/ml, BR reduced cell prolifera- tion in all tumor cells but not in non-tumor cells (i.e., 45% reduction in MCF-7, p<0.001). An additive effect of BR with therapeutic drugs was observed on reduction of cell viability (MCF-7 cells: BR: 14% reduction, 10 μM tamoxifen (Tx): 53% reduction, BR+Tx: 67% re- duction; MDA-MB-231 cells: BR: 25% reduction, 10 nM paclitaxel (Px): 36% reduction, BR+Px: 53% reduction). Using a colorimetric assay, we detected a 24 % increase in caspase activity after 12 h (p<0.05), suggesting a BR-mediated apoptosis induction. Oxidative stress was not induced after BR exposure. From the original etha- nolic extract, three different fractions were obtained by extraction with different solvents: chloroform, ethyl acetate, methanol-water. In MCF-7 and MDA-MB-231 cells, reduced cell viability was observed only after incubation with the chloroform fraction, indicating the pres- ence of bioactive molecules responsible for the cytotoxic effect. In conclusion, these results demonstrate the antiproliferative proper- ties of BR on breast cancer cells. Moreover, a new additive effect of clinical therapeutic drugs and BR in tumoral cells was described.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa